nsc 664704 has been researched along with Kidney Diseases in 1 studies
kenpaullone: inhibits CDK1/cyclin B; structure in first source
kenpaullone : An indolobenzazepine that is paullone in which the hydrogen at position 9 is replaced by a bromo substituent. It is an ATP-competitive inhibitor of cyclin-dependent kinases (CDKs) and glycogen synthase kinase 3beta (GSK3beta).
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, HW | 1 |
| Arif, E | 1 |
| Altintas, MM | 1 |
| Quick, K | 1 |
| Maheshwari, S | 1 |
| Plezia, A | 1 |
| Mahmood, A | 1 |
| Reiser, J | 1 |
| Nihalani, D | 1 |
| Gupta, V | 1 |
1 other study available for nsc 664704 and Kidney Diseases
| Article | Year |
|---|---|
High-content screening assay-based discovery of paullones as novel podocyte-protective agents.
Topics: Actin Cytoskeleton; Animals; Apoptosis; Benzazepines; Cell Line; Disease Models, Animal; Doxorubicin | 2018 |